Proton Beam Therapy
Radiation Therapy for Ventricular Tachycardia
Recruiting1 awardPhase 1 & 2
New York, New York
This trial is looking at whether giving a lower dose of treatment all at once is as effective and safe as dividing it into three smaller doses for patients with a heart condition called refractory ventricular tach
Photo of person injecting drugs for Opioid Use Disorder
Recruiting1 award1 criteria
Baltimore, Maryland
The aim of this study was to evaluate the effects of exposure to drug-related photos used by the media on emotions, stigma towards people who use drugs, and public health services for this population.
Prompt for Common Cold
Recruiting1 award5 criteria
Wilmington, Delaware
A retrospective real-world data study, assessing the relationship between the timing of Budesonide/Glycopyrrolate/Formoterol initiation following an exacerbation and the occurrence of subsequent exacerbations, severe cardiopulmonary events and other real-world outcomes in the United States
Behavioral Intervention
MyPEEPS Mobile Plus for HIV Prevention
Recruiting1 award3 criteria
New York, New York
"This trial aims to use a mobile app to provide HIV prevention information to young men who have sex with men (YMSM). The researchers want to see if combining this app with virtual peer support will
Popular Filters
Phase 3 Trials
Corticosteroid
Baxdrostat + Dapagliflozin for Chronic Kidney Disease and High Blood Pressure
Recruiting1 awardPhase 3
Surprise, Arizona
This trial will test a new medication called Baxdrostat with Dapagliflozin to see if it can improve kidney health and reduce the risk of heart problems in people with chronic kidney
Neurokinin Inhibitor
Fosaprepitant vs Metoclopramide for Nausea and Vomiting
Recruiting1 awardPhase 2 & 3
Bronx, New York
This trial aims to compare the effectiveness and side effects of a new anti-nausea medication called fosaprepitant with the standard medication metoclopramide. Fosaprepitant works in
Anti-bacterial
Doxycycline for STDs Prevention
Recruiting2 awardsPhase 3
Los Angeles, California
This trial aims to see if taking doxycycline can help prevent bacterial sexually transmitted infections in people who were assigned female at birth. It will also look at how well the treatment is accepted and
Cardiac Myosin Activator
Omecamtiv Mecarbil for Heart Failure
Recruiting1 awardPhase 3
Camp Hill, Pennsylvania
This trial aims to determine if a new drug, omecamtiv mecarbil, can lower the chances of hospitalization, heart transplantation, or death in patients with heart failure and severely reduced heart
Hyaluronic Acid Gel
NOA VOLUME Gel for Midface Volume Loss
Recruiting2 awardsPhase 3
Metairie, Louisiana
"This trial is testing a new gel called NOA VOLUME that is used to restore volume in the mid-face for people looking to rejuvenate their appearance. The gel is being compared to an existing treatment
Trials With No Placebo
Behavioral Intervention
Lifestyle and Sleep Intervention for Obesity
Recruiting1 award3 criteria
Philadelphia, Pennsylvania
This trial aims to see how making lifestyle changes and improving sleep habits can affect weight loss in teenagers. Participants will receive remote coaching on weight loss and sleep for 16 weeks and will be monitored through assessments
Behavioral Intervention
Positive Emotion Upregulation for Schizophrenia
Recruiting1 award2 criteria
Piscataway, New Jersey
This trial aims to understand how attention and different ways of thinking affect decision-making and brain processes in individuals with schizophrenia or schizoaffective disorder compared to those without these conditions. The study will also investigate
Post surgical (non-cardiac) PACU patients with anticipated overnight stay. for Complications
Recruiting1 award5 criteria
Baltimore, Maryland
Investigators will enroll 320 patients who will undergo non-cardiac surgery, receive supplemental oxygen via face mask, and will be on a continuous pulse oximetry monitor in the Post Anesthesia Care Unit (PACU). The enrollment criteria were adapted from a previous study that showed SpO2 values seriously underestimated the severity of post-operative hypoxemia in patients with and without specific risk factors for hypoxemia. Research personnel will screen and ensure that each subject meets the enrollment criteria, and the informed consent is properly executed. Upon arrival to the PACU, each subject will be fitted with oxygen mask containing the Linshom sensor, which will be connected to a Linshom monitor for data collection. A side stream capnography line will be connected to the same face mask and the capnography data will be collected on the Zoe Medical 740 SELECTâ„¢ monitor. Additionally, two pulse oximeters will be applied to the same hand (non- NIBP arm), one of which will be connected to a hospital monitor (SoC) and the other to a Zoe Medical 740 SELECTâ„¢ monitor. The Linshom and 740 SELECTâ„¢ monitors will collect data once every second. Research personnel will then initiate the Linshom CPRM baseline mode and begin recording any clinical intervention (e.g., medications, oxygen delivery change, and stimulation upon detection of changes in patient's condition) that is performed by the PACU staff, paying close attention to, and recording of time at which those interventions occurred. Data collection will be performed throughout the subject's entire PACU stay. The CPRM data collection will be performed passively while the patient is monitored via SoC and will not interfere with clinical interventions that may take place during the data collection. Clinical staff in the PACU will be blinded to the Linshom CPRM data as well as pulse oximetry (non-SOC monitor) and capnography data collected.
Infrequent for Gestational Diabetes
Recruiting1 award6 criteria
New York, New York
This is a prospective double arm study in patients with Gestational Diabetes Mellitus (GDM) utilizing frequent (single fingerstick on admission) vs infrequent glucose monitoring in labor (q 4 hours in latent labor and every 2 hours in active labor). Primary Objective: The primary outcome is glucose value of the neonate at birth. Secondary Objectives: Determine rates of insulin requirements within different monitoring techniques. Determine if there is a difference in neonatal intensive care unit (NICU) admission within different monitoring techniques. Determine neonatal blood glucose concentrations at 24 hours of life, number of glucose treatments, and neonatal hyperbilirubinemia. Secondary characteristics to be viewed for each diagnosis; BMI, race, age, and parity.
COPD Patients for Common Cold
Recruiting1 award4 criteria
Wilmington, Delaware
Patients with chronic obstructive pulmonary disease (COPD) have elevated risk of mortality and cardiopulmonary events, particularly following exacerbations. While single inhaler triple therapies (SITTs), such as budesonide/glycopyrrolate/formoterol fumarate (BGF), reduce mortality and cardiopulmonary event risk versus dual bronchodilator therapy, there is limited evidence comparing outcomes associated with SITTs versus multiple inhaler triple therapies (MITTs). SKOPOS-MAZI was a retrospective comparative effectiveness study in patients with COPD aged ≥40 years using US administrative claims data from Optum's de-identified Clinformatics® Data Mart Database. The primary and secondary endpoints were time to all-cause mortality (ACM) and time to first severe cardiopulmonary event following initiation of BGF or MITT (identification period: October 1, 2020-June 30, 2023; index date: first prescription fill). Relative hazards of outcomes were assessed until a censoring event using Cox proportional hazards models, with inverse propensity treatment weighting accounting for between-group imbalances (standardized mean difference \>0.1) in baseline characteristics.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.